m/s / COVID-19
Open Access
Numéro
Med Sci (Paris)
Volume 37, Numéro 6-7, Juin-Juillet 2021
m/s / COVID-19
Page(s) 565 - 568
Section Le Magazine
DOI https://doi.org/10.1051/medsci/2021065
Publié en ligne 3 juin 2021
  1. Zhao J, Yang Y, Huang HP, et al. Relationship between the ABO blood group and the COVID-19 susceptibility. Clin Infect Dis 2020; ciaa1150. doi : 10.1093/cid/ciaa1150. [Google Scholar]
  2. Cheng Y, Cheng G, Chui CH, Lau FY ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA 2005 ; 293 : 1450–1451. [Google Scholar]
  3. Le Pendu J, Breiman A, Rocher J, et al. ABO blood types and Covid-19: spurious, anecdotal, or truly important relationships? A reasoned review of available data. Viruses 2021; 13 : 160. [CrossRef] [PubMed] [Google Scholar]
  4. Galili U. Human natural antibodies to mammalian carbohydrate antigens as unsung heroes protecting against past, present, and future viral infections. Antibodies (Basel) 2020; 9 : 25. [Google Scholar]
  5. Guillon P, Clément M, Sébille V, et al. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology 2008 ; 18 : 1085–1093. [CrossRef] [PubMed] [Google Scholar]
  6. Deleers M, Breiman A, Daubie V, et al. Covid-19 and blood groups: ABO antibody levels may also matter. Int J Infect Dis 2021; 104 : 242–9. [CrossRef] [PubMed] [Google Scholar]
  7. Stowell SR, Stowell CP Biologic roles of the ABH and Lewis histo-blood group antigens part II: thrombosis, cardiovascular disease and metabolism. Vox Sang 2019 ; 114 : 535–552. [CrossRef] [PubMed] [Google Scholar]
  8. Kiechl S, Pare G, Barbalic M, et al. Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. Circ Cardiovasc Genet 2011 ; 4 : 681–686. [CrossRef] [PubMed] [Google Scholar]
  9. Sardu C, Marfella R, Maggi P, et al. Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovasc Disord 2020; 20 : 373. [CrossRef] [PubMed] [Google Scholar]
  10. Ellis PJI. Modelling suggests blood group incompatibility may substantially reduce SARS-CoV-2 transmission. Epidemics 2021. doii: 10.1016/j.epidem.2021.100446. [Google Scholar]
  11. O’Driscoll M, Ribeiro Dos Santos G, Wang L, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature 2021; 590 : 140–5. [CrossRef] [PubMed] [Google Scholar]
  12. Priyadrasini SL, Suresh M. Factors influencing the epidemiological characteristics of pandemic COVID 19: A TISM approach. Int J Healthcare Management 2020; 13 : 89–98. [Google Scholar]
  13. Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev 2015 ; 28 : 801–870. [CrossRef] [PubMed] [Google Scholar]
  14. Breiman A, Ruvën-Clouet N, Le Pendu J. Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2. PLoS Pathog 2020; 16 : e1008556. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.